Literature DB >> 3011250

Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics.

C A Pritsos, A C Sartorelli.   

Abstract

Mitomycin C (MC) is a naturally occurring anticancer agent which has been shown to be more cytotoxic to hypoxic tumor cells than to their aerobic counterparts. The mechanism of action of this agent is thought to involve biological reductive activation, to a species that alkylates DNA. A comparison of the cytotoxicity of MC to EMT6 tumor cells with that of the structural analogues porfiromycin (PM), N-(N',N'-dimethylaminomethylene)amine analogue of mitomycin C (BMY-25282), and N-(N',N'-dimethylaminomethylene)amine analogue of porfiromycin (BL-6783) has demonstrated that PM is considerably less cytotoxic to aerobic EMT6 cells than MC, whereas BMY-25282 and BL-6783 are significantly more toxic. The relative abilities of each of these compounds to generate oxygen free radicals following biological activation were measured. Tumor cell sonicates, reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase, xanthine oxidase, and mitochondria were used as the biological reducing systems. All four mitomycin antibiotics produced oxygen radicals following biological reduction, a process that may account for the aerobic cytotoxicity of agents of this class. The generation of relative amounts of superoxide and hydroxyl radical were also measured in EMT6 cell sonicates. BMY-25282 and BL-6783 produced significantly greater quantities of oxygen free radicals with the EMT6 cell sonicate, reduced nicotinamide adenine dinucleotide phosphate-cytochrome c reductase, and mitochondria than did MC and PM. In contrast, BMY-25282 and BL-6783 did not generate detectable levels of free radicals in the presence of xanthine oxidase, whereas this enzyme was capable of generating free radicals with MC and PM as substrates. MC consistently produced greater amounts of free radicals than PM with all of the reducing systems. BMY-25282, BL-6783, and MC all generated hydroxyl radicals, while PM did not appear to form these radicals. The findings indicate that a correlation exists between the ability of the mitomycin antibiotics to generate oxygen radicals and their cytotoxicity to aerobic EMT6 tumor cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3011250

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

2.  Theoretical studies of the reduction reaction of the anti-tumor drug FR900482.

Authors:  Anne-Marie Sapse; Duli C Jain
Journal:  J Mol Model       Date:  2006-09-23       Impact factor: 1.810

3.  Tumor growth and metastasis can be inhibited by maintaining genomic stability in cancer cells.

Authors:  Yi Liang; Qisheng Feng; Jian Hong; Futuo Feng; Yi Sang; Wenrong Hu; Miao Xu; Roujun Peng; Tiebang Kang; Jinxin Bei; Yixin Zeng
Journal:  Front Med       Date:  2015-02-07       Impact factor: 4.592

4.  Characterization of a mitomycin-binding drug resistance mechanism from the producing organism, Streptomyces lavendulae.

Authors:  P J Sheldon; D A Johnson; P R August; H W Liu; D H Sherman
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

Review 5.  Cellular pharmacology of quinone bioreductive alkylating agents.

Authors:  S Rockwell; A C Sartorelli; M Tomasz; K A Kennedy
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

6.  Inhibition of mitomycin C's aerobic toxicity by the seleno-organic antioxidant PZ-51.

Authors:  D L Gustafson; C A Pritsos
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

7.  Differential effect of nitrogen species on changes in mitochondrial membrane permeability due to mitomycin c in lung epithelial cells.

Authors:  Se Young Park; Hyun Hee Ko; Jin Ho Song; Eun Sook Han; Chung Soo Lee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-07       Impact factor: 3.000

Review 8.  Modulation of tumor cell response to chemotherapy by the organ environment.

Authors:  I J Fidler; C Wilmanns; A Staroselsky; R Radinsky; Z Dong; D Fan
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

Review 9.  Hypoxia and drug resistance.

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1994-06       Impact factor: 9.264

10.  Cardiotoxicity of mitomycin A, mitomycin C, and seven N7 analogs in vitro.

Authors:  R T Dorr; N G Shipp; J D Liddil; B S Iyengar; K R Kunz; W A Remers
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.